Prospective evaluation of a colorectal cancer nurse follow-up clinic

被引:8
作者
Jeyarajah, S. [1 ]
Adams, K. J. [1 ]
Higgins, L. [1 ]
Ryan, S. [2 ]
Leather, A. J. M. [1 ]
Papagrigoriadis, S. [1 ]
机构
[1] Kings Coll Hosp London, Dept Colorectal Surg, London SE5 9RS, England
[2] Kings Coll Hosp London, Dept Radiol, London SE5 9RS, England
关键词
Colorectal cancer; surveillance; follow up; cost effectiveness; nurse clinic; QUALITY-OF-LIFE; CURATIVE RESECTION; LOCAL RECURRENCE; RECTAL-CANCER; MESORECTAL EXCISION; SURVIVAL; MANAGEMENT; SURGERY; IMPACT; PROGNOSIS;
D O I
10.1111/j.1463-1318.2009.02027.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Colorectal Nurse Specialist (CNS) clinics for postoperative follow up of colorectal cancer aim to maintain clinical efficacy while reducing costs. We prospectively studied the efficacy and financial implications of such a clinic. Method This was a prospective study of all patients attending CNS clinics over 3 years. A lower-risk protocol for patients with Dukes A was used over 3 years and a higher-risk protocol for patients with Dukes B, C or D was used over 5 years. Department of Health Pricing Charts were used to cost the follow-up protocols, and adjustment was performed to calculate the cost of each quality adjusted life year (QALY) gained. Results One hundred and ninety-three patients entered into this nurse-led follow-up protocol implemented by the CNS clinic between 2005 and 2007. The Dukes stages and proportions of patients in each stage were as follows: stage A, 13%; stage B, 8%; stage C, 36.3%; and stage D, 9.3%. Ninety-seven per cent underwent curative treatment and 2.6% had palliative treatment. Twenty-one per cent of patients developed recurrent disease. Overall actuarial 5-year survival was 80% and recurrences had a 30% 5-year actuarial survival. The total cost per patient for 3 years of follow up was 1506 pound and 1179 pound for lower-risk rectal and nonrectal cancers, respectively. The adjusted cost for each QALY gained for lower-risk tumours was 1914 pound. The total cost per patient with higher-risk tumours was 1814 pound and 1487 pound for rectal and nonrectal tumours, respectively. The adjusted cost for each QALY gained was 2180 pound for higher-risk tumours. Conclusions This clinic demonstrated cost-effective detection of recurrent disease. Computed tomography (CT) was the most sensitive alert test. As all recurrences were detected within 4 years, we suggest that this is the indicated time to follow up.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [41] Prospective evaluation of follow-up in melanoma patients in Germany - Results of a multicentre and longitudinal study
    Livingstone, E.
    Krajewski, C.
    Eigentler, T. K.
    Windemuth-Kieselbach, C.
    Benson, S.
    Elsenbruch, S.
    Hauschild, A.
    Rompel, R.
    Meiss, F.
    Mauerer, A.
    Kaehler, K. C.
    Dippel, E.
    Moellenhoff, K.
    Kilian, K.
    Mohr, P.
    Utikal, J.
    Schadendorf, D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (05) : 653 - 667
  • [42] Role of surveillance imaging and endoscopy in colorectal cancer follow-up: Quality over quantity?
    Liu, Shiru L.
    Cheung, Winson Y.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (01) : 59 - 68
  • [43] Strategies of follow-up for colorectal cancer: A survey of the American society of colon and rectal surgeons
    Giordano P.
    Efron J.
    Vernava III A.M.
    Weiss E.G.
    Nogueras J.J.
    Wexner S.D.
    Techniques in Coloproctology, 2006, 10 (3) : 199 - 207
  • [44] Intensive follow-up vs conventional follow-up for patients with non-metastatic colorectal cancer treated with curative intent: A meta-analysis
    Cui, Li-Li
    Cui, Shi-Qi
    Qu, Zhong
    Ren, Zhen-Qing
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (12)
  • [45] Follow-up after curative treatment for colorectal cancer: longitudinal evaluation of patient initiated follow-up in the first 12 months
    L. Batehup
    K. Porter
    H. Gage
    P. Williams
    P. Simmonds
    E. Lowson
    L. Dodson
    N. J. Davies
    R. Wagland
    J. D. Winter
    A. Richardson
    A. Turner
    J. L. Corner
    Supportive Care in Cancer, 2017, 25 : 2063 - 2073
  • [46] Nurse-led follow-up care for head and neck cancer patients: a quasi-experimental prospective trial
    de Leeuw, Jacqueline
    Prins, Judith B.
    Teerenstra, Steven
    Merkx, Matthias A. W.
    Marres, Henri A. M.
    van Achterberg, Theo
    SUPPORTIVE CARE IN CANCER, 2013, 21 (02) : 537 - 547
  • [47] Clinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma
    Wieldraaijer, Thijs
    Bruin, Pascal
    Duineveld, Laura A. M.
    Tanis, Pieter J.
    Smits, Anke B.
    van Weert, Henk C. P. M.
    Wind, Jan
    DIGESTIVE SURGERY, 2018, 35 (01) : 35 - 41
  • [48] Colonoscopy Surveillance After Colorectal Cancer: the Optimal Interval for Follow-Up
    Winesh Ramphal
    Jeske R. E. Boeding
    Jennifer M. J. Schreinemakers
    Paul D. Gobardhan
    Harm J. T. Rutten
    Rogier M. P. H. Crolla
    Journal of Gastrointestinal Cancer, 2020, 51 : 469 - 477
  • [49] Evidence-based follow-up in colorectal cancer—quo vadis?
    Manuel Maglione
    Alexander Perathoner
    memo - Magazine of European Medical Oncology, 2020, 13 : 64 - 68